Skip to main content

Proposed rule updates for the Radiation Oncology Model

The new Radiation Oncology alternative payment model will start Jan. 1, 2022, after the proposal is finalized in the calendar year 2022 Outpatient Prospective Payment System and Ambulatory Surgical Center Payment System final rule, scheduled for early November. This rule will require prospective hospital outpatient departments, physician practices and freestanding clinics providing radiation therapy services to adopt a prospective bundled payment model with new clinical and quality measure reporting requirements.

The model is mandatory for participants selected by CMS.

The new RO model includes several notable changes that must be addressed for successful participation:

Disease sites update

The criteria for cancer types have been clarified. Cancer types must be:

  • commonly treated with radiation therapy according to nationally recognized evidence-based guidelines;
  • associated with ICD-10 codes that demonstrate pricing stability; and
  • not determined to be unsuitable for inclusion by the HHS Secretary.

As a result of the updated criteria, liver cancer was removed since there is limited guidance for first line use of radiotherapy for treatment. Sixteen cancer types remain included under the proposed RO Model.

Modalities of treatment update

Most radiation therapy services will be covered, including treatment planning, dose planning, radiation physicians and dosimetry, treatment devices, image guidance, special services, treatment delivery and treatment management.

Brachytherapy was removed from the list of included radiation therapy treatment modalities. The removal of this modality came out of concern for how episodes using two or more types of radiation therapy treatment would be handled and the potential disincentive its inclusion in the RO Model could create for cases where it is clinically indicated.

Performance period update:

The baseline period was updated to the CY 2017-2019 period if the model begins in 2022. This performance period impacts the calculation of national base rates and participant-specific adjustment factors that determine the professional component and technical component episode payment amounts for participants.

In addition, the discount factors were proposed to be lowered by 0.25% for each component of the model.

RO Model participant update

CMS issued a ZIP code list detailing the locations of prospective participants. These include physician group practices, freestanding centers and hospital-based outpatient departments providing radiation therapy specific episodes of care.

Several RO participant exclusions were modified:
  • Hospital outpatient departments participating in the Pennsylvania Rural Health Model will not be eligible to participate.
  • HOPDs in the Community Transformation track of the CHART Model will not be eligible to participate.
  • HOPDs in the ACO Transformation track of the CHART Model will be eligible to participate in the RO Model and CMS will apply the same overlap policy that has been proposed for MSSP ACOs.

Exclusion criteria update

An extreme and uncontrollable circumstances policy is proposed for the RO Model, allowing flexibilities to reduce administrative burdens associated with participating in the model when there is an extreme or uncontrollable circumstance affecting an entire region or locale. This allows CMS to amend the model performance period, eliminate or delay reporting requirements or amend the pricing methodology under the RO Model when there is an extreme or uncontrollable circumstance declared impacting a provider’s ability to deliver care according to the model requirements.

How to prepare

To ensure successful participation, healthcare providers must begin planning now for these proposed rule updates, new quality measures and reporting requirements. Learn how DataGen can help your practice prepare for this new alternative payment model through Performance Period Monitoring for Alternative Payment Models.

Comments

Popular posts from this blog

Unlock the Potential of Value-based Payment

A common misconception in healthcare practices: Organizations can quickly reap the benefits of value-based payment transformation. To launch a successful value-based payment program , practices must implement a variety of foundational pieces. It may take time, resources and data before a practice can successfully engage in VBP. In this blog, we'll cover what goes into VBP and its potential benefits. We'll also dig deeper into practice advancement strategies and how they can help you achieve your practice goals. What goes into VBP? Many practices want to implement VBP because of its payment structure and return on investment. Yet, they might not consider how to nurture a successful VBP program in their organization. It starts with a gap analysis regarding people, processes and technologies. It’s important to celebrate what is working well and intervene where improvement can be made. Successful VBP starts with the practice team. There are many perceptions vs. realities that exist

BPCIA: 4 fast facts for a successful Model Year 7 kickoff

Participation in Model Year 7 launched on Jan. 1, 2024, with the first few months being a critical time for providers. New Bundled Payments for Care Improvement Advanced Model (BPCIA) participants got their footing, and continuing participants were able to change their clinical episode service line groups for the first time since 2020.  If you’re a provider participating in this model, read on for a BPCIA refresher and four fast facts for starting MY7 right. We’ll also cover core analytics activities to support your clinical and operational success.   4 Fast facts on BPCIA Model Year 7  1.   Focus on clinical episodes and episode volume  Before MY7 began, providers used historic baseline data provided by CMS to evaluate which CESLGs they would go at risk for, ensuring there would be sufficient episode volume. Large episode volume (100 episodes/year or more) reduces random variation and helps protect providers from financial risk associated with outlier Medicare episode spend.    During